Credit Agricole S A Vertex Pharmaceuticals Inc Transaction History

Credit Agricole S A

$36.5 Billion
Q3 2025

A detailed history of Credit Agricole S A transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Credit Agricole S A holds 62,387 shares of VRTX stock, worth $27.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

62,387

Previous 55,672 12.06%

Holding current value

$27.1 Million

Previous $27 Million 9.47%

% of portfolio

0.07%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$366.54 - $479.53 $2.46 Million - $3.22 Million	6,715 Added 12.06%	62,387 $24.4 Million
Q1 2025 May 14, 2025	SELL	$402.49 - $513.76 $16.5 Million - $21.1 Million	-41,043 Reduced 42.44%	55,672 $27 Million
Q4 2024 Feb 14, 2025	SELL	$396.64 - $516.74 $710,778 - $925,998	-1,792 Reduced 1.82%	96,715 $38.9 Million
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $8.54 Million - $9.38 Million	18,555 Added 23.21%	98,507 $45.8 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $12.3 Million - $15.2 Million	31,359 Added 64.53%	79,952 $37.5 Million

Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $6.79 Million - $7.43 Million	16,663 Added 52.19%	48,593 $20.3 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $6.14 Million - $7.35 Million	17,899 Added 127.57%	31,930 $13 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $3.42 Million - $3.67 Million	-10,127 Reduced 41.92%	14,031 $4.88 Million
Q2 2023 Jul 31, 2023	SELL	$314.42 - $351.91 $179,848 - $201,292	-572 Reduced 2.31%	24,158 $8.5 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $579,205 - $660,739	-2,045 Reduced 7.64%	24,730 $7.79 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $3.89 Million - $4.38 Million	13,618 Added 103.5%	26,775 $7.73 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $2.95 Million - $3.29 Million	10,763 Added 449.58%	13,157 $3.81 Million
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $398,962 - $496,749	1,698 Added 243.97%	2,394 $675,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $11,071 - $13,048	-50 Reduced 6.7%	696 $181,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $525,124 - $587,656	-2,895 Reduced 79.51%	746 $135,000
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $542,033 - $639,200	2,891 Added 385.47%	3,641 $734,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $2.37 Million - $2.76 Million	-11,430 Reduced 93.84%	750 $161,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $2.49 Million - $3.33 Million	12,046 Added 8989.55%	12,180 $2.88 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $8,692 - $10,305	34 Added 34.0%	134 $36,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $22,548 - $29,580	-100 Reduced 50.0%	100 $29,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $32,745 - $38,940	200 New	200 $37,000
Q4 2017 Feb 13, 2018	SELL	$137.28 - $155.55 $8.44 Million - $9.56 Million	-61,479 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $673,398 - $737,543	4,546 Added 7.98%	61,479 $9.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	56,933	56,933 $7.34 Million

Others Institutions Holding VRTX

# of Institutions

1,786

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.

Account

Credit Agricole S A Vertex Pharmaceuticals Inc Transaction History